{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:53:23Z","timestamp":1783688003337,"version":"3.55.0"},"reference-count":33,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"DOI":"10.1210\/jc.2017-02622","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T19:07:31Z","timestamp":1517598451000},"page":"1704-1714","source":"Crossref","is-referenced-by-count":52,"title":["A Comparative Analysis of Phenotypic Predictors of Mutations in Familial Hypercholesterolemia"],"prefix":"10.1210","volume":"103","author":[{"given":"Dick C","family":"Chan","sequence":"first","affiliation":[{"name":"School of Medicine, University of Western Australia, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Pang","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Western Australia, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J","family":"Hooper","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Western Australia, Perth, Western Australia, Australia"},{"name":"Department of Clinical Biochemistry, PathWest Laboratory Medicine, Royal Perth Hospital and Fiona Stanley Hospital Network, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damon A","family":"Bell","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Western Australia, Perth, Western Australia, Australia"},{"name":"Department of Clinical Biochemistry, PathWest Laboratory Medicine, Royal Perth Hospital and Fiona Stanley Hospital Network, Perth, Western Australia, Australia"},{"name":"Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R","family":"Bates","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Western Australia, Perth, Western Australia, Australia"},{"name":"St. John of God Midland Public and Private Hospitals, Midland, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R","family":"Burnett","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Western Australia, Perth, Western Australia, Australia"},{"name":"Department of Clinical Biochemistry, PathWest Laboratory Medicine, Royal Perth Hospital and Fiona Stanley Hospital Network, Perth, Western Australia, Australia"},{"name":"Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F","family":"Watts","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Western Australia, Perth, Western Australia, Australia"},{"name":"Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,2,2]]},"reference":[{"issue":"5","key":"key\n\t\t\t\t20180406135416_B1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/aje\/kwh237","article-title":"Familial hypercholesterolemia and coronary heart disease: a HuGE association review","volume":"160","author":"Austin","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"4","key":"key\n\t\t\t\t20180406135416_B2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ncpcardio0836","article-title":"Mechanisms of disease: genetic causes of familial hypercholesterolemia","volume":"4","author":"Soutar","year":"2007","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"key\n\t\t\t\t20180406135416_B3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijcard.2015.03.027","article-title":"Prevalence and treatment of familial hypercholesterolaemia in Australian communities","volume":"185","author":"Watts","year":"2015","journal-title":"Int J Cardiol"},{"issue":"17","key":"key\n\t\t\t\t20180406135416_B4","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/eurheartj\/ehw028","article-title":"Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217","volume":"37","author":"Benn","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180406135416_B5","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"issue":"2","key":"key\n\t\t\t\t20180406135416_B6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.atherosclerosis.2012.07.030","article-title":"Genetic analysis of familial hypercholesterolaemia in Western Australia","volume":"224","author":"Hooper","year":"2012","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20180406135416_B7","doi-asserted-by":"crossref","unstructured":"Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group. Atherosclerosis. 1999;142(1):105\u2013112.","DOI":"10.1016\/S0021-9150(98)00200-7"},{"issue":"2","key":"key\n\t\t\t\t20180406135416_B8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9149(93)90155-6","article-title":"Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics","volume":"72","author":"Williams","year":"1993","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180406135416_B9","unstructured":"World Health Organization. Familial hypercholesterolemia (FH): report of a second WHO consultation. Available at: http:\/\/apps.who.int\/iris\/bitstream\/10665\/66346\/1\/WHO_HGN_FH_CONS_99.2.pdf. Accessed 10 January 2018."},{"issue":"5","key":"key\n\t\t\t\t20180406135416_B10","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jacl.2016.07.011","article-title":"US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry","volume":"10","author":"Ahmad","year":"2016","journal-title":"J Clin Lipidol"},{"issue":"22","key":"key\n\t\t\t\t20180406135416_B11","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","article-title":"The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association","volume":"132","author":"Gidding","year":"2015","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180406135416_B12","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ijcard.2015.08.146","article-title":"Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia","volume":"201","author":"Chan","year":"2015","journal-title":"Int J Cardiol"},{"issue":"1","key":"key\n\t\t\t\t20180406135416_B13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.atherosclerosis.2015.03.003","article-title":"Clinical experience of scoring criteria for familial hypercholesterolaemia (FH) genetic testing in Wales","volume":"240","author":"Haralambos","year":"2015","journal-title":"Atherosclerosis"},{"issue":"19-20","key":"key\n\t\t\t\t20180406135416_B14","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.cca.2011.05.036","article-title":"Lipoprotein(a)-cholesterol: a significant component of serum cholesterol","volume":"412","author":"Kinpara","year":"2011","journal-title":"Clin Chim Acta"},{"issue":"4","key":"key\n\t\t\t\t20180406135416_B15","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1194\/jlr.D045963","article-title":"LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias","volume":"55","author":"Johansen","year":"2014","journal-title":"J Lipid Res"},{"issue":"6","key":"key\n\t\t\t\t20180406135416_B16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"issue":"1","key":"key\n\t\t\t\t20180406135416_B17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.atherosclerosis.2004.12.001","article-title":"The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population","volume":"180","author":"Damgaard","year":"2005","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20180406135416_B18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.atherosclerosis.2017.06.917","article-title":"Evaluation of clinical and laboratory parameters used in the identification of index cases for genetic screening of familial hypercholesterolemia in Brazil","volume":"263","author":"Silva","year":"2017","journal-title":"Atherosclerosis"},{"issue":"9","key":"key\n\t\t\t\t20180406135416_B19","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.amjcard.2008.06.056","article-title":"Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia","volume":"102","author":"Civeira","year":"2008","journal-title":"Am J Cardiol"},{"issue":"22","key":"key\n\t\t\t\t20180406135416_B20","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"key\n\t\t\t\t20180406135416_B21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/heartjnl-2012-302917","article-title":"Effectiveness of alternative strategies to define index case phenotypes to aid genetic diagnosis of familial hypercholesterolaemia","volume":"99","author":"Clarke","year":"2013","journal-title":"Heart"},{"issue":"6","key":"key\n\t\t\t\t20180406135416_B22","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jacl.2016.08.011","article-title":"Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: frequencies, associations and predictions","volume":"10","author":"Ellis","year":"2016","journal-title":"J Clin Lipidol"},{"issue":"6","key":"key\n\t\t\t\t20180406135416_B23","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCRESAHA.115.304660","article-title":"Mutations in STAP1 are associated with autosomal dominant hypercholesterolemia","volume":"115","author":"Fouchier","year":"2014","journal-title":"Circ Res"},{"issue":"9874","key":"key\n\t\t\t\t20180406135416_B24","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","article-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study","volume":"381","author":"Talmud","year":"2013","journal-title":"Lancet"},{"issue":"7","key":"key\n\t\t\t\t20180406135416_B25","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/14737159.2017.1332997","article-title":"Recent advances in genetic testing for familial hypercholesterolemia","volume":"17","author":"Iacocca","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"issue":"3","key":"key\n\t\t\t\t20180406135416_B26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1586\/erc.13.7","article-title":"Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomes","volume":"11","author":"Alonso","year":"2013","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"3","key":"key\n\t\t\t\t20180406135416_B27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijcard.2013.11.025","article-title":"Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation","volume":"171","author":"Watts","year":"2014","journal-title":"Int J Cardiol"},{"issue":"36","key":"key\n\t\t\t\t20180406135416_B28","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"Eur Heart J"},{"issue":"11","key":"key\n\t\t\t\t20180406135416_B29","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1136\/heartjnl-2015-308824","article-title":"A new electronic screening tool for identifying risk of familial hypercholesterolaemia in general practice","volume":"102","author":"Troeung","year":"2016","journal-title":"Heart"},{"issue":"1","key":"key\n\t\t\t\t20180406135416_B30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jacl.2017.01.002","article-title":"Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia","volume":"11","author":"L\u00e1zaro","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"4","key":"key\n\t\t\t\t20180406135416_B31","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/jama.2017.8543","article-title":"Cascade screening for familial hypercholesterolemia and the use of genetic testing","volume":"318","author":"Knowles","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"key\n\t\t\t\t20180406135416_B32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/MOL.0000000000000398","article-title":"The role of registries and genetic databases in familial hypercholesterolemia","volume":"28","author":"Kindt","year":"2017","journal-title":"Curr Opin Lipidol"},{"issue":"10","key":"key\n\t\t\t\t20180406135416_B33","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1161\/01.ATV.0000183888.48105.d1","article-title":"The use of Achilles tendon sonography to distinguish familial hypercholesterolemia from other genetic dyslipidemias","volume":"25","author":"Junyent","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/4\/1704\/24565765\/jc.2017-02622.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T04:44:52Z","timestamp":1603773892000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/103\/4\/1704\/4835371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,2]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,2,2]]},"published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2017-02622","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2018,2,2]]}}}